IP Library Granted Patent US 8,221,990
Granted Patent B2
US 8,221,990 · App. 12/257,351 · Granted Jul 17, 2012

Screening GPR12 receptor for substances having Nesfatin-1-like action, or which regulate Nesfatin-1 action

Assignees: Teijin Pharma Limited; National University Corporation Gunma University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,221,990
App. No.
12/257,351
Granted
Jul 17, 2012
Kind
B2
Abstract

An object of the present invention is to identify a Nesfatin-1 receptor, and to provide a method for screening or designing a Nesfatin-1-action regulating substance or a Nesfatin-1-like action substance using the Nesfatin-1 receptor. A method for screening a Nesfatin-1-like action substance comprising steps of making a test substance act on a receptor protein selected from the group consisting of GPR3, GPR6 and GPR12, and of identifying the Nesfatin-1-like action substance based on a change of Nesfatin-1 action.

Claims (10)

1. A method for screening for a substance that has Nesfatin-1-like action, said method comprising:

contacting isolated cells with a test substance, wherein the isolated cells express GPR12; and

identifying that the test substance is a substance that has Nesfatin-1-like action when the test substance binds with the receptor or activates the signal transduction ability of the receptor;

wherein Nesfatin-1-like action is an action for suppressing food intake and/or body weight gain.

2. The screening method according to claim 1 , wherein the test substance is a peptide or a peptide analog obtained by modifying a peptide having the amino acid sequence represented by any of SEQ ID NOs: 1 to 3 or 11 to 37.

3. A method for screening for a substance that regulates Nesfatin-1 action, said method comprising:

contacting isolated cells with a test substance in the presence of Nesfatin-1, wherein the isolated cells express GPR12; and

identifying a test substance that regulates Nesfatin-1 action based on a change of the binding capacity of Nesfatin-1 with the receptor, or a change of the signal transduction ability of the receptor;

wherein when the test substance inhibits the binding between Nesfatin-1 and the receptor, or decreases the intensity or frequency of the signal transduction, the test substance is identified as a substance inhibiting Nesfatin-1 action, and wherein when the test substance facilitates the binding between Nesfatin-1 and the receptor, or increases the intensity or frequency of the signal transduction, the test substance is identified as a substance facilitating Nesfatin-1 action;

wherein Nesfatin-1-like action is an action for suppressing food intake and/or body weight gain.

Assignments (2)
COPORATE SPLIT Recorded Jan 18, 2013
From: TEIJIN PHARMA LIMITED
To: TEIJIN LIMITED
Reel/Frame 029660/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2009
From: MORI, MASATOMO; EGUCHI, HIROSHI
To: TEIJIN PHARMA LIMITED; NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
Reel/Frame 022292/0850 →
Continuity (3)
Continuation In Part 12098279 · Apr 4, 2008
Provisional Application 60907542 · Apr 6, 2007
Related Publication 20090233325A1 · Sep 17, 2009